Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Obesity × Ketorolac × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Breast 1

Conditions

Pain, Postoperative 1 Pain 1 Obesity 1 Multiple Myeloma 1 Lymphoma 1 Kidney Neoplasms 1 Inflammation 1 Carcinoma, Renal Cell 1 Breast Neoplasms 1 Agnosia 1

Interventions

semaglutide 3 Metformin 3 Tirzepatide 2 Tablets 2 Specimen Handling 2 Observation 2 Exercise 2 Counseling 2 Caloric Restriction 2 mirabegron 1 atezolizumab 1 Weights and Measures 1 Walk Test 1 Therapeutics 1 TIC10 compound 1 Standard of Care 1 Spermine Synthase 1 Progestins 1 Pregabalin 1 Population Groups 1 Omeprazole 1 Nutrition Assessment 1 Negative-Pressure Wound Therapy 1 Methods 1 Metabolic Networks and Pathways 1 Megestrol Acetate 1 Liraglutide 1 Letrozole 1 LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1 Ketorolac 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡